Biomarker Discovery

Early Detection of Liver Disease and Cancer

The Baruch S. Blumberg Institute is using state-of-the-art mass spectroscopy-assisted discovery of antigenic epitopes from hepatitis B and C-infected cells, as well as other technologies to discover epitopes that might have therapeutic value and serve as early detection markers of cancer. New assays for the detection of liver cancer and colorectal cancer are also being developed, using novel genomic and proteomic methods.